Hutch News

Hutch News

Stories tagged 'Molecular basis of cancer '

Dr. Raphael Gottardo awarded pilot funding from Chan Zuckerberg Initiative

The one-year project will adapt a statistical platform to support the Human Cell Atlas, a global cell-mapping research project

April 27, 2018 | By Rachel Tompa / Fred Hutch News Service

Fred Hutch computational biologist Dr. Raphael Gottardo has received funding from the Chan Zuckerberg Initiative as part of a global research effort to map every type of cell in the human body.

View story >


Dr. Sue Biggins elected to American Academy of Arts & Sciences

Biologist is ninth Hutch researcher to join one of the nation's oldest learned societies

April 18, 2018 | By Rachel Tompa / Fred Hutch News Service

The American Academy of Arts & Sciences has announced its 238th class of new members, including Fred Hutch biologist Dr. Sue Biggins.

View story >


Dr. Sita Kugel receives $100K grant to study pancreatic neuroendocrine tumors

She will use preclinical models to study the role of DNA packaging in cancer development and metastasis

March 29, 2018 | By Sabrina Richards / Fred Hutch News Service

View story >


Science to watch in 2018: From immunotherapy to gene therapy, big data to new tech

Fred Hutch experts lend their predictions for the coming year’s advances

Jan. 12, 2018 | By Rachel Tompa / Fred Hutch News Service

We asked Fred Hutch researchers for their predictions on scientific advances to watch in the coming year. Look for their tips on what's next in cancer immunotherapy, precision oncology, gene editing, infectious disease research, cancer prevention and more.

View story >


10 highlights of Fred Hutch science in 2017

A look back at notable discoveries in cancer immunotherapy, HIV prevention and more

Dec. 28, 2017 | by Sabin Russell and Susan Keown / Fred Hutch News Service

It's been a year of breakthroughs at Fred Hutch. Here are 10 of our favorites.

View story >


Good News at Fred Hutch

Celebrating faculty and staff achievements

Dec. 21, 2017

When it comes to cancer, there’s no shortage of potential drug targets — many molecules are thrown out of whack when tumors develop. But finding a drug that specifically works against these aberrant molecules is another task entirely. Now, a group led by Fred Hutchinson Cancer Research Center scientists has designed a small protein from scratch that specifically blocks a protein known as TEAD that plays a role in many different cancers.

View story >



(RSS feeds are best viewed in browsers other than Chrome)

Editor's Picks

GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Magazine Archive
Back issues of Hutch Magazine

Financial Reporting
Fiscal highlights & Annual Reports

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.